Table 1.
Demographic Characteristics at Enrollment: All Enrolled Set
| Prior GBS | Prior Placebo | Naïve | ||||
|---|---|---|---|---|---|---|
| Parent Study Vaccine | GBS No Adj | GBS Alum | GBS MF59 Full | GBS MF59 Half | Placebo | Not Applicable |
| Extension Study Vaccine | GBS No Adj | GBS No Adj | GBS No Adj | GBS No Adj | GBS No Adj | GBS No Adj |
| N = 14 | N = 14 | N = 10 | N = 15 | N = 6 | N = 21 | |
| Mean age ± SD, y | 32.4 ± 6.9 | 31.6 ± 6.1 | 29.7 ± 6.2 | 28.9 ± 4.7 | 28.3 ± 5.4 | 29.2 ± 7.0 |
| Caucasian ethnicity, n | 14 | 14 | 10 | 15 | 6 | 21 |
| Mean weight ± SD, kg | 73.1 ± 12.5 | 63.4 ± 6.9 | 67.6 ± 12.3 | 62.9 ± 8.2 | 62.5 ± 7.9 | 62.8 ± 6.4 |
| Mean height ± SD, cm | 168.9 ± 5.4 | 166.1 ± 4.9 | 170.5 ± 5.1 | 164.4 ± 7.1 | 163.3 ± 5.0 | 169.0 ± 6.0 |
| Mean body mass index ± SD, kg/m2 | 25.7 ± 4.6 | 23.0 ± 2.6 | 23.2 ± 3.4 | 23.3 ± 2.9 | 23.5 ± 4.0 | 22.0 ± 2.2 |
| Mean time between parent and extension study vaccination ± SD, y | 5.8 ± 0.06 | 5.8 ± 0.05 | 5.5 ± 0.05 | 5.5 ± 0.06 | 5.7 ± 0.13 | NA |
Abbreviations: alum, aluminum hydroxide-adjuvanted formulation; GBS, group B streptococcus; MF59 full, full-dosage MF59-adjuvanted formulation; MF59 half, half-dosage MF59-adjuvanted formulation; N, number of enrolled women in each group; n, number of women in the specified category; no adj, nonadjuvanted formulation; SD, standard deviation.